24-Hour Intraocular Pressure Control with Fixed-dose Combination Brinzolamide 1%/Brimonidine 0.2%: A Multicenter, Randomized Trial. [electronic resource]
Producer: 20200304Description: 1095-1104 p. digitalISSN:- 1549-4713
- Aged
- Antihypertensive Agents -- therapeutic use
- Brimonidine Tartrate -- therapeutic use
- Carbonic Anhydrase Inhibitors -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glaucoma, Open-Angle -- drug therapy
- Humans
- Intraocular Pressure -- drug effects
- Male
- Middle Aged
- Ocular Hypertension -- drug therapy
- Prospective Studies
- Sulfonamides -- therapeutic use
- Thiazines -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.